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The present report describes a very rare case of synchronous primary pulmonary adenocarcinoma and
MALToma in a patient with Sjo¨gren’s syndrome. A 73-year-old woman with a history of Sjo¨gren’s
syndrome was referred because of an abnormal shadow on X-ray. Chest radiograph revealed an irreg-
ularly shaped mass in the right lower lobe of the lung. Computed tomography showed a parenchymal
lesion with an air bronchogram and spiculated contours. Chronic inﬂammation was seen on trans-
bronchial lung biopsy, but clinically a pulmonary malignant tumor was suspected. No obvious abnor-
mality other than that of the lung was detected. The patient underwent a right lower lobectomy with
mediastinal lymph node dissection. The histological features of the surgical specimen were consistent
with bronchiolo-alveolar carcinoma and, separately, MALT lymphoma.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
The synchronous occurrence of primary pulmonary MALToma
and adenocarcinoma is an extremely rare clinical phenomenon,
with only two cases reported in the English medical literature thus
far.1,2 Simultaneous MALToma and adenocarcinoma in a patient
with Sjo¨gren’s syndrome has not been previously reported. Here
we present a very rare case in which a patient with Sjo¨gren’s
syndrome synchronously developed a primary pulmonary adeno-
carcinoma and MALToma.2. Case
A 73-year-old woman was referred to our hospital for further
examination after the detection of an abnormal shadow on X-ray.
She was asymptomatic and a non-smoker but had a history of
Sjo¨gren’s syndrome beginning at age 60 years. Chest radiograph
revealed an irregularly shaped mass with a maximum diameter of
4 cm in the right lower lobe of the lung (Fig. 1A). Computed
tomography showed a parenchymal lesion with a 4-cm maximum
axis, air bronchogram, and spiculated contours (Fig. 1B). On
a positron emission tomography scan, the lesion had an increased
standard uptake value of 2.58, with no uptake in the left lung. No: þ81 27 243 3380.
iyoshihara).
rved.obvious uptake other than in the lung was detected. There was no
elevation of tumor markers (carcinoembryonic antigen, squamous
cell carcinoma antigen, neuron-speciﬁc enolase, interleukin-2) and
the other laboratory data were also within the normal range.
Chronic inﬂammation was seen on transbronchial lung biopsy, but
it was difﬁcult to establish a diagnosis in the absence of a biopsy
specimen. Based on the patient’s history of Sjo¨gren’s syndrome,
pulmonary malignant lymphoma with only lung involvement was
suspected. She underwent video-assisted thoracoscopic surgery, in
which a right lower lobectomy with mediastinal lymph node
dissection was performed.
The resected specimen consisted of a mass of 3.5 3.4 2.2 cm
(Fig.1C) andhistological features consistentwith bronchiolo-alveolar
carcinoma.Thecolumnarepithelial cellswereatypicallyoval inshape,
with enlarged nuclei and abundant acidophilic cytoplasm (Fig. 2A).
This proliferation of atypical cells was accompanied by an inﬁltration
of inﬂammatory cells (lymphocytes and plasma cells) that extended
along the peripheral alveolar walls (Fig. 2B). In an area distinct from
the adenocarcinoma, clusters of lymphocytes and plasma cells, some
with germinal centers,were noted, often ina peribronchiolar location
(Fig. 2C). In addition, the lymphocytes had inﬁltrated and destroyed
the epithelial cells (#4). Immunohistochemical examination showed
CD20-positive lymphoid cells (Fig. 2D) and a reactive T-cell pop-
ulation expressing CD5. The adenocarcinoma cells were positive for
keratin AE1/AE3 as were the alveolar epithelial cells. Partial lym-
phoepithelial lesions featuring lymphocyte inﬁltration and sur-
rounded by scattered l-chain-positive cells were observed. Based on
Fig. 1. A, Chest radiograph revealing an irregularly shaped mass with a maximum diameter of 4 cm in the right lower lobe of the lung (black arrow). B, Computed tomography
showing a parenchymal lesion with a 4-cm maximum axis localized to the right lower lobe, with air bronchogram and spiculated contours (white arrow). C, The resected specimen
consisting of a 3.5 3.4 cm mass (black arrow).
M. Kamiyoshihara et al. / Respiratory Medicine CME 4 (2011) 27–2928the morphology of the lesions, a diagnosis of primary pulmonary
adenocarcinoma associated with low-grade malignant B-cell
lymphoma of mucosa-associated type (MALToma) was made.
Macroscopically, the bronchiolo-alveolar carcinoma was a whitish
lesion located slightly apart from the MALT lymphoma. Examination
of the dissected lymph nodes showed reactive follicular hyperplasiaFig. 2. A, Histological ﬁndings indicating bronchiolo-alveolar carcinoma. The columnar epith
B, Inﬂammatory cells, such as lymphocytes and plasma cells, inﬁltrated the lesion and accum
in a peribronchiolar location. D, Immunohistochemical examination showing CD20-positiveand sinus histiocytosis, without evidence of lymphoma or carcinoma.
The postoperative pathology staging indicated T2N0M0 stage IB
disease.
The patient is currently receiving postoperative adjuvant
chemotherapy and there has been no recurrence of the tumor 20
months post-operatively.elial cells are atypically oval with enlarged nuclei and abundant acidophilic cytoplasm.
ulated along the peripheral alveolar walls. C, Clusters of lymphocytes and plasma cells
lymphoid cells.
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Primary pulmonary non-Hodgkin’s lymphomas are rare
neoplasms, accounting for only 3.6% of extranodal lymphomas.3 Of
these pulmonary tumors, the majority (78%4) are low-grade B-cell
MALTomas. After the stomach, the lung is the second most
common extranodal site of involvement.5 Moreover, if the two
tumors were located far enough apart from each other, such as in
different lobes of the ipsilateral lung or in the contralateral lung,
their simultaneous occurrence may well have been coincidental.
However, in the case of an adjacent tumor, such as a collision
tumor or two different tumors in the same pulmonary lobe, it can
well be assumed that the two tumors are somehow related. For
example, synchronous tumors might develop because the ﬁrst
tumor provokes formation of the second; alternatively, the two
tumors might arise independently but in response to the same
carcinogen.6
The present case is not a collision tumor between adenocarci-
noma and MALT lymphoma. However, the etiology of this
synchronous lesion is uncertain because there are few reports of
synchronous primary pulmonary adenocarcinoma and MALToma.
Both tumors are known to occur in the gastrointestinal tract and
the etiology of the pulmonary tumors may be similar. In gastric
lesions, adenocarcinoma and MALToma are often associated with
concomitant Helicobacter pylori (HP) infection.7,8 Indeed, HP is
a major etiological factor in the development of gastrointestinal
adenocarcinoma and MALToma.8 Furthermore, Epstein-Barr virus
(EBV)-encoded RNA 1 has been detected in primary synchronous
gastric adenocarcinoma associatedwith lymphoma.7 In our patient,
however, EBV was not detected via immunohistochemical exami-
nation, and May-Gru¨nwald staining for HP organisms in lung
lesions is currently not possible. Thus, a common etiological link to
HP infection cannot be conﬁrmed.
Sjo¨gren’s syndrome is an autoimmune disease characterized by
the presence of B- cell hyper-reactivity. An additional predominant
feature is abnormal B-cell activity, such as germinal centerformation, which is manifested by massive polyclonal B-cell acti-
vation and the synthesis of anti-Ro (SS-A) and anti-La (SS-B) auto-
antibodies.9 Patients with Sjo¨gren’s syndrome often develop B-cell
lymphomas9 and thus have high serum levels of B-cell activating
factor.10 Therefore, Sjo¨gren’s syndrome might play an important
role in the development of both the lymphoma and the carcinoma,
providing a unifying event underlying the pathogenesis of these
two types of tumors.
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